Akathisia Awareness can Reduce Suicide

Akathisia Awareness Saves Lives

Adverse drug effects are a leading cause of patient harm and death

Nobody is immune to akathisia.”

— Wendy Dolin, MISSD Founder

CHICAGO, IL, US, September 19, 2020 /EINPresswire.com/ — September is Suicide Prevention Month, and September 20th is designated International Akathisia Awareness Day by the Medication-Induced Suicide Prevention and Education Foundation in Memory of Stewart Dolin (MISSD). Akathisia is a disorder induced by various medications that can cause a person to experience such intense inner restlessness that the sufferer is driven to violence, self-harm, and suicide.

"The COVID-19 epidemic has increased public awareness of adverse drug effects," said Wendy Dolin, founder of MISSD. "Prescriptions for medications that can cause akathisia have increased since the virus started. In addition, some drugs explored as possible COVID-19 cures can cause akathisia. Other medications associated with akathisia risks include various drugs prescribed for acne, asthma, malaria, and depression. Now more than ever, it is time to talk about akathisia."

"The World Health Organization states adverse drug effects are common causes of patient harm affecting millions of people every year," said Dolin. "Unfortunately, akathisia is an adverse drug effect that is frequently misdiagnosed and improperly treated. Nobody is immune to akathisia."

While mental health challenges do not precipitate akathisia-induced deaths in the same way as in traditional suicides, suicide prevention organizations and crisis hotlines can help reduce these avoidable deaths by asking questions about medications and adverse drug effects.

"Patient safety is a team effort," said Dolin. "Healthcare consumers should obtain informed consent and discuss risk info with their doctors and pharmacists. Carefully read the medication leaflet that accompanies prescriptions, and be aware of the Food and Drug Administration (FDA) black box warnings," said Dolin.

The FDA black box warnings are the most vital warnings pharmaceutical products can carry. Selective Serotonin Reuptake Inhibitors (SSRIs) to include Prozac, Zoloft, and Paxil, have FDA black box warnings about suicidality. MISSD recommends that consumers identify a medication buddy to help monitor for any unusual behavior changes whenever stopping, starting, or changing doses of SSRIs and other medications that can cause akathisia.

MISSD's educational resources include an accredited, 1-hour online course, two public health videos, an akathisia podcast series, a YouTube channel, and informative brochures. Dolin will also be discussing akathisia on Susan Guthrie's September 28th "The Divorce and Beyond" podcast.

"Many suicide prevention organizations and mental health nonprofits have strong financial ties to the pharmaceutical industry," said Dolin. "MISSD takes no funding from the pharmaceutical industry, and all our resources are available to the public at no charge."

Wendy Dolin
+1 847-910-2346
email us here
Visit us on social media:

What is Akathisia?

Source: EIN Presswire

An Open Letter To Our Biden-Harris Team

Identify with the mind and with it heal the brain.

Emotional intelligence comes from emotional health.

Brain Education Is At The Door. Please Embrace It.

Emotionally Healthy Brain Generates Emotional Intelligence.

Ever since Trump announced his candidacy I have posted hundred of articles and comments why Trump is unfit to be president. I also protested in front of Trump T

The difference between Trump & Biden is Trump is insane and Biden is emotionally healthy. Trump displays all the character traits of ignorance, Biden's wisdom is his chief asset & is on full display.”

— Sajid Khan

RIDGEFIELD PARK, NEW JERSEY, USA, September 19, 2020 /EINPresswire.com/ — Please consider me on your speech writing, debate coaching, advertising and policy teams.

Not only is Biden the most well prepared for the White House he has this extraordinary quality of giving up his long held solutions if something better turns up. Given Biden's openness to innovation America has a good chance to finally over come its biggest crisis of being emotionally challenged and become an Emotional Health Super Power. I will provide the step by step plan that will enhance our Biden-Harris agenda.

Biden & Harris can accomplish what no president has done ever, solve once & for all America's #1 problem of America being an emotionally challenged country.

Biden and Harris will hopefully focus on emotional health (EH) America's #1 problem. EH is the panacea for all the social ills of society and yet there is no testing or manual for EH. No wonder American society is messed up. Now even the Social Progress Institute, that consists of several Nobel Prize winners, is calling for a wake up call to take action on our deteriorating social standards.


Both Biden and Harris have extraordinary grit and pooled together their grit is squared. It took Obama-Biden's extraordinary grit to do what no president could accomplish: healthcare reform. Still the healthcare problem was well known. Biden-Harris have a chance to tackle the #1 problem of America being an emotionally challenged country. Throughout history the emotional health crisis has remained undiscovered & unsolved.

Emotional health being messed up means health, education, society are all messed up. Drug addiction, divorce, tense relationships, unhappiness. crime and corruption, sleeplessness, inflated defense budgets, suicide, finances are all a mess. Crime alone costs a trillion dollars. All because we miseducate the brain.

For the first time in history America will become an emotional health super power!

I have a one of a kind expertise that America and the world needs. Whether I am added to your policy team or not I would still like to share my innovations for you to use to win the election and then to implement for the greater good.

Please review the following to decide if I deserve to be on your policy team.


Here is my hypothesis: https://youtu.be/nmzwj-W8Mww

Here is my shortcut to a wise society: http://www.einpresswire.com/article/379533579/creating-definitions-that-make-the-world-wise


How to reform education. blob:https://www.facebook.com/1f76bfed-1f2e-4c45-9774-e0ced34190e4

Please review the following to decide if I deserve to be on your debate coaching, speech writing, and advertising teams. I have posted over 200 comments in NY Times and all over explaining why Trump is unfit to be a mayor of a small village let alone the White House, as he is the slave of his insane gut. Here is a sample:

The main step towards making America great again is to make America sane again. The right step is to have the right leadership in the White House. We need to replace insanity with wisdom.

The difference between Trump and Biden is that Trump is emotionally challenged and Biden is the very epitome of emotional health. While Trump displays all the character traits of ignorance Biden's wisdom is his chief asset and is on full display.

No matter how many expert briefings Trump attends and his mind soaks up the new information, and changes his opinion in light of the new information. His brain sticks to its insane gut's entrenched opinion and forces the mind to revert to its beliefs. It is like a student comes in with his half-baked knowledge and the new lessons go in one ear and go out the next. Naturally when the test comes up the student has learnt nothing new and so ends up with a D. The question is can America afford another four years of Trump's insane gut's rule?

For a president when his knowledge is not up to the mark, he is still successful when he follows and implements the expert's policy. In the case of Trump, his expert in chief above and beyond all experts; is his own insane gut so Trump follows and implements it's D grade solutions, ignoring the better available solutions. Even his appointments are selected by his insane gut which believes it does not need expert advice as it itself is the top expert on all matters. So it appoints those who tow its agenda and consider it as the last word on all issues. The litmus test for employment in the Trump White House is loyalty and mediocre expertise is fine. Those who don't tow the insane gut's line are fired.

Presidents improve with experience but Trump's insane phony overconfidence has kept him chained to his D grade competence.

Trump has two sets of opinions on any given issue. What his mind knows and what his brain feels. Which opinion will emerge in his speech depends on whether he is in the mind mode or the brain mode. Trump is a brain person more than a mind person. Unfortunately his brain is emotionally challenged. It is his brain that is the boss. So he filters reality through his insane feelings about it. The mind's knowledge is overruled by his insane brain's own make belief reality.

His brain believes that by virtue of being the commander in chief he is also the expert in chief and not just in any one field but in all fields. Thus he does not only not consult many experts to decide policy he does not hire the best experts just those who believe that he is the last expert on all issues. His brain handicap is compounded by the fact that he sleeps less than four hours. So his tired brain projects a tired mind, brain and body. I am willing to help him with deep brain relaxation that he needs desperately.

Letting an insane brain lead the war against the virus is itself pure insanity. Steps must be taken to ensure that insanity is never again allowed to compete for the White House. The limits of presidential powers must be more clearly defined and any president showing signs of insanity must be removed from office, without going through the impeachment process.

Trump's emotional health is a mess. His adviser in chief is his insane gut that has an insane mind of its own. His insanity cannot distinguish between having the ultimate power, which he does have being the commander in chief and ultimate expertise which he is far from having. Not only does his gut feel that it has the authority to rule by presidential orders over the entire congress and country, it has the authority to be the expert in chief on all issues. So every single day he lectures on and on as if he is the expert authority. He does not even have the capacity to realize that his knowledge is based on misinformation supplied by his insane gut.

What I have said a thousand times and even published in the NY Times hundreds of times is now being said by a team of Nobel Prize winners that Trump is a symptom of America's declining trend. That America must wake up and take action towards removing this massive crisis. I have not only been highlighting this problem for the last 50+ years I have been defining the fundamental cause and cure for this mess. Please review all my published comments on your page and take over my plan as your own. Please I need to hand over my emotional health activism to your Biden-Harris Team. I have already done the hard work and you can make it center stage where action can be taken. My wisdom formula has trillion dollar applications and peace and happiness it will bring is priceless.

Another reason I deserve to be on your team is because I have protested against Trump at his headquarters hundreds of times with banners and t-shirts. I even have a leadership test that Trump failed. I posted it on Fox News and GOP's page. I challenged them to prove me wrong that Trump is insane. They are silent. I have scientifically proved Trump's insanity.

At the last Trump convention I held a banner at the entrance to the arena in Cleveland saying that 'I will give $1000.00 to anyone who can prove that Trump is not insane'. Not one persons out of tens of thousands who walked passed the banner, took up my challenge.





4th R Foundation
+1 201-450-8098
email us here
Visit us on social media:

My basic hypothesis that has applications in ed., health, society, relationships, happiness, peace, deep brain relaxation, upbringing, wisdom, focus etc

Source: EIN Presswire

1 Percent Low Fat Milk Market Analysis Report 2020 by Supply, Demand, Components, Trends, Size, Share and more…

A new market study, titled “Global 1 Percent Low Fat Milk Market Professional Survey Report 2019”, has been featured on WiseGuyReports.

PUNE, MAHARASTRA, INDIA, September 19, 2020 /EINPresswire.com/ — 1 Percent Low Fat Milk Market

Milk is a nutrient-rich, white liquid food produced by the mammary glands of mammals. 1 Percent Reduced Fat Milk is considered reduced-fat milk. This report focuses on 1 Percent Low Fat Milk volume and value at global level, regional level and company level. From a global perspective, this report represents overall 1 Percent Low Fat Milk market size by analyzing historical data and future prospect.

Regionally, this report categorizes the production, apparent consumption, export and import of 1 Percent Low Fat Milk in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their 1 Percent Low Fat Milk manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Organic Valley
Aurora Organic
Borden Dairy
Garelick Farms
Guida's Dairy
HP Hood
Maola Milk
Prairie Farms
Producers Dairy

Request Free Sample Report at https://www.wiseguyreports.com/sample-request/4508866-global-1-percent-low-fat-milk-market-professional-survey-report-2019

Segment by Regions
North America
Southeast Asia

Segment by Type

Segment by Application
Daily Food

View Detailed Report at https://www.wiseguyreports.com/reports/4508866-global-1-percent-low-fat-milk-market-professional-survey-report-2019

About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

email us here

Source: EIN Presswire

Heart Health Ingredients Market Analysis Report 2020 by Supply, Demand, Components, Trends, Size, Share and more…

A new market study, titled “Global Heart Health Ingredients Market Professional Survey Report 2019”, has been featured on WiseGuyReports.

PUNE, MAHARASTRA, INDIA, September 19, 2020 /EINPresswire.com/ — Heart Health Ingredients Market

Heart health ingredients keep heart healthy heart and prevents human body from factors leading to cardiovascular diseases. High blood pressure, high cholesterol level, and excess weight are the major risk factors for the cardiovascular diseases. The commonly used heart health ingredients include omega-3, beta glucan, phytosterol, soy protein, and others. Omega-3 is the majorly used ingredient for heart health and it helps to decrease triglycerides, lower blood pressure, reduce blood clotting, decrease stroke and heart failure risk, and reduce irregular heartbeats. Increasing prevalence of cardiovascular diseases across the globe has opened various opportunities to the food and beverage industry to include heart health ingredients in their products.

Regionally, this report categorizes the production, apparent consumption, export and import of Heart Health Ingredients in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Heart Health Ingredients manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Archer Daniels Midland
Aker Biomarine
Andean Grain Products
Bioriginal Food & Science Corporation
Croda International

Request Free Sample Report at https://www.wiseguyreports.com/reports/4511392-global-heart-health-ingredients-market-professional-survey-report-2019

This report focuses on Heart Health Ingredients volume and value at global level, regional level and company level. From a global perspective, this report represents overall Heart Health Ingredients market size by analyzing historical data and future prospect.

Segment by Regions
North America
Southeast Asia

Segment by Type
Beta Glucan
Soy Protein

Segment by Application
Dairy and Frozen Desserts
Sweet and Savory Snacks

View Detailed Report at https://www.wiseguyreports.com/reports/4511392-global-heart-health-ingredients-market-professional-survey-report-2019

About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

email us here

Source: EIN Presswire

Baby Formula Oil Ingredients Market Analysis Report 2020 by Supply, Demand, Components, Trends, Size, Share and more…

A new market study, titled “Global Baby Formula Oil Ingredients Market Insights, Forecast to 2025”, has been featured on WiseGuyReports.

PUNE, MAHARASTRA, INDIA, September 19, 2020 /EINPresswire.com/ — Baby Formula Oil Ingredients Market

This report studies the global market size of Baby Formula Oil Ingredients in key regions like North America, Europe, China and Japan, focuses on the consumption of Baby Formula Oil Ingredients in these regions. This research report categorizes the global Baby Formula Oil Ingredients market by top players/brands, region, type and end user.

This report also studies the global Baby Formula Oil Ingredients market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Bunge Loders Croklaan
Advanced Lipids
Wilmar(Yihai Kerry)
Graincorp Foods
Fuji Oil Holdings
Stepan International

Request Free Sample Report at https://www.wiseguyreports.com/sample-request/4547510-global-baby-formula-oil-ingredients-market-insights-forecast-to-2025

Baby Formula Oil Ingredients market size by Type
Other Oils and Fats

Baby Formula Oil Ingredients market size by Applications
0-6 Months Baby
6-12 Months Baby
12-36 Months Baby

Market size by Region
North America
United States
South Korea
Central & South America
Middle East & Africa
GCC Countries
South Africa

The study objectives of this report are:
To study and analyze the global Baby Formula Oil Ingredients market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Baby Formula Oil Ingredients market by identifying its various sub segments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Baby Formula Oil Ingredients companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Baby Formula Oil Ingredients submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

View Detailed Report at https://www.wiseguyreports.com/reports/4547510-global-baby-formula-oil-ingredients-market-insights-forecast-to-2025

About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

email us here

Source: EIN Presswire

Bactronix Flourishes Amidst Disinfection Industry Boom

Disinfection industry and Bactronix see impressive growth due to the impact of Covid-19

MOON TOWNSHIP, PA, UNITED STATES, September 18, 2020 /EINPresswire.com/ — Amid the 2020 Covid-19 pandemic, the disinfection industry has boomed. Bactronix, a disinfection company with revolutionary technology, has risen to the top in the market throughout the industry’s growth thanks to a diverse offering of services and products.

Due to the pandemic, consumers have become more health aware and the numbers prove it. According to a recent study by Global View Research, "the global surface disinfectant market size was estimated at USD 1.4 billion in 2019 and is expected to register a compound annual growth rate (CAGR) of 7.6% from 2020 to 2027." (1) Yet another study by Arizton states that the electrostatic sprayer segment of the market is expected to reach $1.9 billion or more by 2025 (2). Companies like Bactronix, which began driving franchise expansion this year, are benefiting from the country’s awareness and push towards more healthy and safe living conditions.

According to Jos Kleynjans, President and CEO of Bactronix and one of the founders of the company, there are many companies in the present market that specialize in one area or another, but not in all areas. "There are labs that do testing, companies the produce disinfectants and sell products retail, businesses that specialize in cleaning, treating and disinfection, but none that do it all,” Kleynjans said. "Bactronix is the one 'One-Stop-Shop' for all of the above. This is the reason that Bactronix is recognized as one of the Top Franchising companies in the U.S.”

Bactronix finds itself in the middle of the boom thanks to its diversified product and services that cover many disinfection industry segments: on-site testing and inspection, specialized disinfection and cleaning, proprietary product lines and distribution channels, and disinfection certification. Bactronix ensures 100% coverage through an electrostatically charged process that doesn't produce harmful VOCs or by-products. Other services provided by Bactronix include dryer vent and air duct cleaning, mold remediation, vapor barriers, and insecticide treatment.

Bactronix invites those interested in learning more about their diversified list of services to their website at www.Bactronix.com. To learn more about the Bactronix franchise opportunity, visit their website at http://www.bactronix.com/franchising-opportunities.

ABOUT Bactronix
Bactronix is an award-winning, science-based microbial control company that uses proprietary products and advanced equipment for a wide range of mold removal and disinfection services. Their certified personnel are highly trained in administering effective, eco-friendly disinfection treatments to commercial and residential facilities.

1 https://www.grandviewresearch.com/industry-analysis/surface-disinfectant-market
2 https://www.reportlinker.com/p05955552/Electrostatic-Disinfectant-Sprayer-Market-Global-Outlook-and-Forecast.html?utm_source=PRN

Jos Kleynjans
+1 412-375-7886
email us here
Visit us on social media:

Source: EIN Presswire

Florida emerges as leader in pharmacogenetics research

Dr. McLeod

Dr. Johnson

Dr. Cavallari

Florida has emerged as a national leader in genetics research specialty

The precision medicine talent in Tampa, Gainesville, and across Florida is making a big difference in people’s lives. This recognition is exciting for Florida.”

— Dr. Howard McLeod

TAMPA, FLORIDA, UNITED STATES, September 18, 2020 /EINPresswire.com/ — TAMPA – The study of pharmacogenetics is not a new one in the world of medical research.

Also referred to as Precision Medicine, pharmacogenetics is a branch of genetics that addresses how our genetic code influences how we respond to drug therapies.

As early as 1957, a published paper noted that adverse reactions to an anti-malarial drug and a muscle relaxant were inherited and linked to deficiencies in the activity of specific liver enzymes. The article established the link between genetics and the enzymes that break down medications.

Florida leading the nation

Which brings us to Florida, home to three of the top five U.S. experts in the field.

Dr. Howard McLeod, medical director of Tampa’s Geriatric Oncology Consortium and a clinical researcher, is ranked No. 1 and Dr. Julie Johnson and Dr. Larisa Cavallari of the University of Florida are ranked No. 4 and No. 5 in the country, according to Expertscape, which ranks experts based on the quality and quantity of their publications.

“The precision medicine talent in Tampa, Gainesville, and across Florida is making a big difference in people’s lives. This recognition is exciting for Florida,” said McLeod, who is also affiliated with USF Taneja College of Pharmacy.

McLeod is also ranked No. 2 in the world in pharmacogenetics behind Professor Sir Munir Pirmohamed of the University of Liverpool in England.

Johnson is the dean of the University of Florida College of Pharmacy. Her research focuses on cardiovascular pharmacogenetics and genomic medicine implementation. She is an internationally recognized expert in the field. Johnson has served on the Nonprescription Drugs Advisory Committee of the FDA, the XDN study section of the NIH.

Cavallari is the director of the University of Florida Center for Pharmacogenomics and Precision Medicine. She also serves as director of the UF Health Precision Medicine Program. Her research involves the discovery and clinical translation of genetic variants related to drug response and has been funded by the NIH, FDA, and the American Heart Association.

Cavallari said the concentration of experts in the field in Florida is helping the state take a lead role in this area of medical research.

“There is a large collection of nationally and internationally recognized experts in pharmacogenetics at universities and health centers across Florida, facilitating multi-site collaborations to advance evidence in the field and implementation of pharmacogenetics in clinical practice,” said Cavallari. “This work not only helps us understand the reason that people respond differently to medications but also, we are able to translate that into improved care of the patient.”

Johnson said UF’s focus on this area of study is reflected in the rankings.

“The University of Florida has intentionally built strength in this area so perhaps it is not surprising that two people from UF are so high on this list,” she said.

Boosted by Human Genome Project

Modern pharmacogenetics research was advanced a hundredfold by the Human Genome Project, which produced a working draft of the human genome in 2000.

“Today, we are learning the language in which God created life,” President Bill Clinton said at the time, paraphrasing Galileo, who insisted that the natural philosophy, even the universe itself, was written in the language of mathematics. “We have caught the first glimpse of our own instruction book. It will revolutionize the diagnosis, prevention, and treatment of most, if not all, human diseases,” he added.

McLeod said the Human Genome Project has revolutionized modern medicine, allowing everything from the diagnosis of babies in the womb to identifying which medicines will work for individual patients.


Last month, the FDA gave clearance to 23andMe, a biotechnology company, allowing its direct-to-consumer personal pharmacogenetics report to guide the use of two treatments without the need for confirmatory testing.

"This expanded indication for our pharmacogenetics report recognizes the accuracy of our results and enables doctors to use them in prescribing therapies," said Anne Wojcicki, CEO of 23andMe. "This is a great milestone in making personalized medicine a reality."

FDA granted 23andMe 510(k) clearance for a pharmacogenetics (PGt) report for interpretive drug information for two medications – clopidogrel, prescribed for certain heart conditions, and citalopram, prescribed for depression. The 510(k) clearance modifies the labeling of the previously authorized 23andMe CYP2C19 Drug Metabolism Report, removing the need for confirmatory testing and allowing the company to provide interpretive drug information based on genetic factors for these specific medications, according to the company.

“It is about empowering people to help guide their own care” added McLeod. “We have entered the age of real-time, patient-controlled medication management,” he said.

David Fierro
Geriatric Oncology Consortium
+1 850-815-1621
email us here

Source: EIN Presswire

Global Covid-19 Vaccine Market Analysis 2020 – Dynamics, Trends, Revenue, Segmented, Outlook & Forecast Till 2026

Latest Market Analysis Research Report on “Global Covid-19 Vaccine Market 2020” has been added to Wise Guy Reports database.

PUNE , MAHARASHTRA, INDIA, September 18, 2020 /EINPresswire.com/ — Global Covid-19 Vaccine Industry

New Study Reports “Covid-19 Vaccine Market 2020 Global Market Opportunities, Challenges, Strategies and Forecasts 2026” has been Added on WiseGuyReports.


The Global Covid-19 Vaccine Market report offers an unbiased analysis by acquiring raw data from private and public databases, archives, and other trustworthy sources. It offers predictions and foresights for the period of 2020 to 2026. The market variables shape the overall landscape with special emphasis on novel trends and emerging opportunities. The market gauges its prospects per region and country to further validate its claims. Prominent players in the industry are profiled and their strategies evaluated for better understanding.

This report focuses on the global Covid-19 Vaccine status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Covid-19 Vaccine development in North America, Europe, China, Japan, South Korea, Middle East, Southeast Asia and Central & South America.

The key players covered in this study
Inovio Pharmaceuticals
Takis Biotech (Evvivax)
Zydus Cadila
Codagenix, Inc.
GeoVax, Inc.
Janssen Pharmaceutical Companies
CanSino Biologics
ExpreS2ion Biotechnologies ApS
Clover Biopharmaceuticals
Vaxil Bio Ltd.
Novavax, Inc.
Sanofi Pasteur
iBio, Inc.
Zydus Cadila
Moderna, Inc.

Try Free Sample of Global Covid-19 Vaccine Market @   https://www.wiseguyreports.com/sample-request/5155348-global-covid-19-vaccine-market-size-status-and-forecast-2020-2026

Competition Landscape

The competition is analyzed with regards to the concentration of players. The Global Covid-19 Vaccine Market trends and patterns are studied and strategies formulated to navigate through various obstacles and unforeseen circumstances. Expansions, agreements, partnerships, mergers, acquisitions, and collaborations are strategies considered by the players to stay afloat in the industry. Range of products are benchmarked and sized according to features, consumer demand, and price.

Market segment by Type, the product can be split into
Live Attenuated Virus
NonReplicating Viral Vecto
Protein Subunit
Market segment by Application, split into

Method of Research

The study of the Global Covid-19 Vaccine Market aims to offer the latest and broadly covered information and for this, our deemed experts have employed the best methods possible, namely the parameters belonging to the Porter’s Five Force Model. The latest inputs have been gathered based on the latest and popular trends and also the names of the key contenders in the market and their extensive chain networks across the globe. Moreover, this section gives an insight into the parent industry, other than the macro-economic aspects and the main governing factors, in terms of the market segmentation. The market research has been extensively carried out by the experts using two effective methods, which are primary and secondary. Both these methods have aided the experts in providing our clients with the best knowledge of the Global Covid-19 Vaccine Market, while focusing on the shortcomings, threats, opportunities and the strengths of the overall market. 


The segments and sub-segments within the Covid-19 Vaccine report are highlighted and expounded in detail with value and growth revenue predictions. The estimations are gained from a SWOT analysis conducted by research analysts and based on the demand-supply chain, consumer sentiment, brand acceptance, and socio-economic factors. Government policies and their impact on the segments are taken into consideration.

Report covers:

Comprehensive research methodology of Global Covid-19 Vaccine Market.
This report also includes detailed and extensive market overview with gap analysis, historical analysis & key analyst insights.
An exhaustive analy sis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the Global Covid-19 Vaccine Market.
Insights about market determinants which are stimulating the Global Covid-19 Vaccine Market.
Detailed and extensive market segments with regional distribution of forecasted revenues
Extensive profiles and recent developments of market players

If you have any enquiry before buying a copy of this report @ https://www.wiseguyreports.com/enquiry/5155348-global-covid-19-vaccine-market-size-status-and-forecast-2020-2026

 Some points from table of content:

1 Report Overview
2 Global Growth Trends by Regions
3 Competition Landscape by Key Players
4 Breakdown Data by Type (2015-2026)
5 Covid-19 Vaccine Breakdown Data by Application (2015-2026)
6 North America
7 Europe
8 China
9 Japan
10 South Korea
11 Middle East
12 Southeast Asia
13 Central & South America
14 Key Players Profiles
14.1 Inovio Pharmaceuticals
14.1.1 Inovio Pharmaceuticals Company Details
14.1.2 Inovio Pharmaceuticals Business Overview and Its Total Revenue
14.1.3 Inovio Pharmaceuticals Covid-19 Vaccine Introduction
14.1.4 Inovio Pharmaceuticals Revenue in Covid-19 Vaccine Business (2015-2020))
14.1.5 Inovio Pharmaceuticals Recent Development
14.2 Takis Biotech (Evvivax)
14.3 Zydus Cadila
14.4 Codagenix, Inc.
14.5 GeoVax, Inc.
14.6 Bravovax
14.7 Janssen Pharmaceutical Companies
14.8 Altimmune
14.9 Vaxart
14.10 CanSino Biologics
14.11 ExpreS2ion Biotechnologies ApS
14.12 Clover Biopharmaceuticals
14.13 GSK
14.14 Vaxil Bio Ltd.
14.15 Generex
14.16 Novavax, Inc.
14.17 Sanofi Pasteur
14.18 Baylor
14.19 iBio, Inc.
14.20 Zydus Cadila
14.21 Moderna, Inc.
14.22 Curevac
14.23 ImmunoPrecise
15 Analyst's Viewpoints/Conclusions
16 Appendix

For more information or any query mail at sales@wiseguyreports.com

Norah Trent
email us here

Source: EIN Presswire

Circular agriculture: “Fly Genetics”, a new European player at the heart of insect production

Circular agriculture: “Fly Genetics”, a new European player at the heart of insect production!

French Groupe Grimaud and Bulgarian start-up Nasekomo announce a joint venture to build a European champion for the supply of improved black soldier flies.

BULGARIA, September 18, 2020 /EINPresswire.com/ — French Groupe Grimaud and Bulgarian Start-up Nasekomo announce the launch of a joint venture to build a European champion to supply the insect-based bioconversion industry with improved black soldier flies.

What is the insect-based bioconversion industry?

The insect-based bioconversion industry aims to transform the agri-food sector into a more sustainable circular economic model by recycling agricultural waste streams into high value-added proteins.

Thanks to the involvement of insects, bioconversion is simple. Many industries produce large amounts of organic by-products that are difficult to recycle, including leftovers from breweries, cereal processing industries, and fruit and vegetable cuttings. These biomasses are fed to black soldier fly larvae, which convert organic nutrients into their own body mass. At maturity, they are harvested and processed into protein that can be included as an ingredient in feed for fish, pets, chickens, and other animals.

Circularity in agriculture brings two major benefits. It allows for recycling and recovery of by-products and decreases the environmental impact of animal production (especially aquaculture) through a more sustainable and efficient input.

Recent studies show that diets including insect-based products produce more robust animals, potentially reducing the need for antibiotics in animal feed.

What are the objectives of Fly Genetics?

Fly Genetics will provide the insect sector with enhanced black soldier flies in order to optimize the conversion of by-products into alternative proteins and other insect-derived products.

Fly Genetics is born from the alliance of a start-up specializing in insect production with experts in genetic selection of animals for efficient protein production.

Uniquely positioned within the circular agriculture revolution, Nasekomo provides clients with insect-based industrial bioconversion solutions that allow for by-product upcycling and processing into alternative proteins and a range of insect-based products.

Looking to innovate further and improve its bioconversion solutions, Nasekomo approached Groupe Grimaud, a group with more than 50 years of experience in animal genetics. The alliance will work together on new black soldier fly strains to increase insect bioconversion efficiency.

Frédéric Grimaud (CEO of the eponymous group) states: “We are happy to apply all of our know-how to a natural diversification of our activities while continuing to support traditional animal sectors through investments focused on sustainability and animal welfare such as sexing duck eggs, or more recently, the inauguration of a new French hatchery with the latest standards in laying hens. For us this means striking the right balance between our flagship activities and the newly emerging ones.”

Marc-Bolard, Nasekomo co-founder, adds: “With this partnership, Nasekomo will nurture its unique position within this new insect industry. This joint venture will naturally enhance our animal population and thus strengthen the economic and environmental impact of insect-based bioconversion: a larger range of by-products will be converted into valuable products with better biological efficiency for increased economic returns. With the support of our proprietary technologies and services, our clients will benefit from tailored, sustainable, and competitive solutions to lead the circular agriculture revolution.”

The new “Fly Genetics” company plans to market its high-performance black soldier flies from the second half of 2021.

About Groupe Grimaud:
Groupe Grimaud is one of the world leaders in multi-species animal genetics, bio-pharmacy and Novel Farming. It has operations in more than 100 countries, generates € 320 M in turnover and employs over 1,800 people worldwide.
The group is mainly family-owned with a head office in Sèvremoine-France (49).
For more information: www.grimaud.com

About Nasekomo:
Nasekomo is a biotech firm that produces alternative insect-based products for animal feed and soil fertilisation. By feeding local agricultural by-products to insects, it contributes to the creation of an environmentally positive local loop. Its robotized insect rearing technology (patent pending) and its genetic selection program enable the company to produce premium insect protein at an industrial scale and a competitive price for the European market. Following its inception, the company obtained € 5 M in funding for the development of its technologies.
For more information: www.nasekomo.life

Press contacts:
• Groupe Grimaud: Julien Leblond, +33670599169, julien.leblond@grimaud.com
• Nasekomo: Xavier Marcenac, +359898952800, xavier.marcenac@nasekomo.life

Xavier Marcenac
+359 898952800
email us here

Source: EIN Presswire

Bio Pharma Buffer 2020 Global Market Outlook,Research,Trends And Forecast To 2024

WiseGuyReports.com Publish A New Market Research Report on –“ Bio Pharma Buffer 2020 Global Market Outlook,Research,Trends And Forecast To 2024”.

PUNE, MAHARASTRA, INDIA, September 18, 2020 /EINPresswire.com/ —

Bio Pharma Buffer Market 2020

Summary: –

The worldwide market for Bio Pharma Buffer is expected to grow at a CAGR of roughly 6.2% over the next five years, will reach 920 million US$ in 2024, from 680 million US$ in 2019, according study.

This report focuses on the Bio Pharma Buffer in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Get a Free Sample Report @ https://www.wiseguyreports.com/sample-request/3765805-global-bio-pharma-buffer-market-2019-by-manufacturers

For more information or any query mail at sales@wiseguyreports.com

Major Key Players Included in This Report are:-

Alfa Aesar (Thermo Fisher)
GE Healthcare
Promega Corporation
Hamilton Company

Bio Pharma Buffer Market has several products under different categories that the major key players pass on to the consumers to help them meet their needs and requirements. The global Bio Pharma Buffer market is a demanding industry that has big popular names as key players for which the revenue generation is high for the market. With the trust of renowned key players, the consumers prefer buying the products with trust, and eventually, it pays off. The global Bio Pharma Buffer market has several perks that assist both residential as well as commercial applications.

The report focuses on the overall market growth of the industry. Along with that, it also consists of the important segmentation factors to give information about the market operation. This report also consists of information related to the regional classification that explains the widespread of the global Bio Pharma Buffer market. The market size of the global Bio Pharma Buffer market was large in the previous forecast period, and with the growing demands, the market size is expected to grow even higher in the present forecast period 2019 to 2024.

Key Segmentation of Bio Pharma Buffer Market 2020

The application segmentation of the global Bio Pharma Buffer market states the popular residential, commercial, or other specific sectors that have implemented or adapted the products/services to meet their operational requirements. Some of the products are meant for residential use, which is also a good choice to select consumers.

The type segmentation of the global Bio Pharma Buffer market states the categories of products available within the market to help the people find the one that they need. Along with that, people must also come up with their operational or usage needs based on which they can choose the ideal products offered by the Bio Pharma Buffer market.

The end-user segmentation of the global Bio Pharma Buffer market is all about giving insight into the types of users who take up these services or products. The end-users are the people for which the market is demanding across the globe.

Overview Based on Region

The region classification intends that the global Bio Pharma Buffer market is spread across various regions of the world. Some of the regions where the market has a stronghold are North America, Europe, Asia Pacific, and other parts of the world. The key players in these regions are evolving their marketing process to reach out to more customers or consumers to help make the market thrive.

Enquiry About Report @ https://www.wiseguyreports.com/enquiry/3765805-global-bio-pharma-buffer-market-2019-by-manufacturers

Table of Contents – Major Key Points

1 Bio Pharma Buffer Market Overview

2 Manufacturers Profiles

3 Global Bio Pharma Buffer Market Competition, by Players

4 Global Bio Pharma Buffer Market Size by Regions

5 North America Bio Pharma Buffer Revenue by Countries

6 Europe Bio Pharma Buffer Revenue by Countries

7 Asia-Pacific Bio Pharma Buffer Revenue by Countries

8 South America Bio Pharma Buffer Revenue by Countries

9 Middle East and Africa Revenue Bio Pharma Buffer by Countries

10 Global Bio Pharma Buffer Market Segment by Type


Buy 1-User PDF @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=3765805

NOTE : Our team is studying Covid-19 and its impact on various industry verticals and wherever required we will be considering Covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.


Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

Norah Trent
646 845 9349 / +44 208 133 9349
email us here

Source: EIN Presswire